Q2 2025 Intuitive Surgical Inc Earnings Call Transcript
Key Points
- Intuitive Surgical Inc (ISRG) reported a strong revenue growth of 21% in the second quarter, driven by solid procedure performance and capital placements.
- The da Vinci procedure growth was 17%, with significant contributions from benign general surgery in the US and non-urology procedures internationally.
- The company placed 395 da Vinci systems, including 180 da Vinci 5 systems, indicating strong capital placements in the US.
- Intuitive Surgical Inc (ISRG) achieved a 23% increase in pro forma earnings per share, reflecting strong financial performance.
- The launch of the da Vinci 5 platform has been well-received, with over 100,000 procedures performed to date and positive customer feedback.
- Intuitive Surgical Inc (ISRG) faces ongoing macroeconomic challenges in international markets, particularly in Japan, China, and Europe, affecting capital placements.
- The company is experiencing downward pressure on gross margins due to higher facilities costs, a greater mix of lower-margin products, and tariffs.
- There is uncertainty regarding the potential impact of US fiscal policy changes on Medicaid recipients, which could affect hospital admissions and financial performance.
- The rollout of the da Vinci 5 platform in Europe and Japan is expected to be measured, with some customers potentially delaying adoption until additional features are available.
- Intuitive Surgical Inc (ISRG) is facing competition from third-party suppliers offering remanufactured instruments, which could impact the company's market share and pricing.
Hello everyone and welcome to the Intuitive second-quarter 2025 earnings release. (Operator Instructions)
Please note, this event is being recorded. Now it's my pleasure to turn the call over to Dan Connolly, head of investor relations. Please go ahead, sir.
Good afternoon, and welcome to Intuitive's second-quarter earnings conference call. With me today, we have Dave Rosa, our CEO; and Jamie Samath, our CFO.
Before we begin, I would like to inform you that comments mentioned on today's call may be deemed to contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in our Securities and Exchange Commission filings, including our most recent 10-K filed on January 31, 2025, and Form 10-Q filed on April 23, 2025.
Our SEC filings can be found through our website or at the SEC's website. Investors are cautioned not to place
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
